100
Participants
Start Date
September 30, 1994
Study Completion Date
June 30, 2002
Interleukin-2
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
National Institute of Allergy and Infectious Diseases (NIAID)
NIH